These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 26068752)

  • 61. Kinetic Basis for DNA Target Specificity of CRISPR-Cas12a.
    Strohkendl I; Saifuddin FA; Rybarski JR; Finkelstein IJ; Russell R
    Mol Cell; 2018 Sep; 71(5):816-824.e3. PubMed ID: 30078724
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Chimeric DNA-RNA Guide RNA Designs.
    Lu S; Zhang Y; Yin H
    Methods Mol Biol; 2021; 2162():79-85. PubMed ID: 32926379
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Rationally engineered Cas9 nucleases with improved specificity.
    Slaymaker IM; Gao L; Zetsche B; Scott DA; Yan WX; Zhang F
    Science; 2016 Jan; 351(6268):84-8. PubMed ID: 26628643
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery.
    Lin S; Staahl BT; Alla RK; Doudna JA
    Elife; 2014 Dec; 3():e04766. PubMed ID: 25497837
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria.
    Gasiunas G; Barrangou R; Horvath P; Siksnys V
    Proc Natl Acad Sci U S A; 2012 Sep; 109(39):E2579-86. PubMed ID: 22949671
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The initiation, propagation and dynamics of CRISPR-SpyCas9 R-loop complex.
    Zeng Y; Cui Y; Zhang Y; Zhang Y; Liang M; Chen H; Lan J; Song G; Lou J
    Nucleic Acids Res; 2018 Jan; 46(1):350-361. PubMed ID: 29145633
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cut site selection by the two nuclease domains of the Cas9 RNA-guided endonuclease.
    Chen H; Choi J; Bailey S
    J Biol Chem; 2014 May; 289(19):13284-94. PubMed ID: 24634220
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Solution structure and dynamics of anti-CRISPR AcrIIA4, the Cas9 inhibitor.
    Kim I; Jeong M; Ka D; Han M; Kim NK; Bae E; Suh JY
    Sci Rep; 2018 Mar; 8(1):3883. PubMed ID: 29497118
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Structure of the miniature type V-F CRISPR-Cas effector enzyme.
    Takeda SN; Nakagawa R; Okazaki S; Hirano H; Kobayashi K; Kusakizako T; Nishizawa T; Yamashita K; Nishimasu H; Nureki O
    Mol Cell; 2021 Feb; 81(3):558-570.e3. PubMed ID: 33333018
    [TBL] [Abstract][Full Text] [Related]  

  • 70. CRISPR Guide RNA Design Guidelines for Efficient Genome Editing.
    Schindele P; Wolter F; Puchta H
    Methods Mol Biol; 2020; 2166():331-342. PubMed ID: 32710418
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Mechanism of duplex DNA destabilization by RNA-guided Cas9 nuclease during target interrogation.
    Mekler V; Minakhin L; Severinov K
    Proc Natl Acad Sci U S A; 2017 May; 114(21):5443-5448. PubMed ID: 28484024
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cas9-catalyzed DNA Cleavage Generates Staggered Ends: Evidence from Molecular Dynamics Simulations.
    Zuo Z; Liu J
    Sci Rep; 2016 Nov; 5():37584. PubMed ID: 27874072
    [TBL] [Abstract][Full Text] [Related]  

  • 73. CRISPR-CAS9 D10A nickase target-specific fluorescent labeling of double strand DNA for whole genome mapping and structural variation analysis.
    McCaffrey J; Sibert J; Zhang B; Zhang Y; Hu W; Riethman H; Xiao M
    Nucleic Acids Res; 2016 Jan; 44(2):e11. PubMed ID: 26481349
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Electronic Circular Dichroism of the Cas9 Protein and gRNA:Cas9 Ribonucleoprotein Complex.
    Halat M; Klimek-Chodacka M; Orleanska J; Baranska M; Baranski R
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805827
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Impact of DNA Topology and Guide Length on Target Selection by a Cytosine-Specific Cas9.
    Tsui TKM; Hand TH; Duboy EC; Li H
    ACS Synth Biol; 2017 Jun; 6(6):1103-1113. PubMed ID: 28277645
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Phylogeny of Cas9 determines functional exchangeability of dual-RNA and Cas9 among orthologous type II CRISPR-Cas systems.
    Fonfara I; Le Rhun A; Chylinski K; Makarova KS; Lécrivain AL; Bzdrenga J; Koonin EV; Charpentier E
    Nucleic Acids Res; 2014 Feb; 42(4):2577-90. PubMed ID: 24270795
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Molecular Mechanisms of RNA Targeting by Cas13-containing Type VI CRISPR-Cas Systems.
    O'Connell MR
    J Mol Biol; 2019 Jan; 431(1):66-87. PubMed ID: 29940185
    [TBL] [Abstract][Full Text] [Related]  

  • 78. DNA stretching induces Cas9 off-target activity.
    Newton MD; Taylor BJ; Driessen RPC; Roos L; Cvetesic N; Allyjaun S; Lenhard B; Cuomo ME; Rueda DS
    Nat Struct Mol Biol; 2019 Mar; 26(3):185-192. PubMed ID: 30804513
    [TBL] [Abstract][Full Text] [Related]  

  • 79. CRISPR-Cas9-Mediated Genome Editing and Transcriptional Control in Yarrowia lipolytica.
    Schwartz C; Wheeldon I
    Methods Mol Biol; 2018; 1772():327-345. PubMed ID: 29754237
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A Biophysical Model of CRISPR/Cas9 Activity for Rational Design of Genome Editing and Gene Regulation.
    Farasat I; Salis HM
    PLoS Comput Biol; 2016 Jan; 12(1):e1004724. PubMed ID: 26824432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.